MIDD in Interstitial Lung Diseases – OFEV® and Beyond

MIDD in Interstitial Lung Diseases – OFEV® and Beyond

Overview of the 2024 MIDD Webinar Series

The 2024 MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.

Julia Korell

Executive Director and US Head of Pharmacometrics

Boehringer Ingelheim

Dr. Julia Korell is an Executive Director and US Head of Pharmacometrics at Boehringer Ingelheim with over 10 years of experience in pharmacometrics and MIDD. She currently leads a team of 8 pharmacometricians that supports over 20 drug development projects across Boehringer Ingelheim’s Inflammation portfolio with MIDD strategies and deliverables from the start of clinical development up to submission and beyond.

As a German native, Julia studied Pharmacy at the University of Freiburg im Breisgau, followed by a PhD in Pharmacometrics at the University of Otago, New Zealand, under the supervision of Prof. Stephen Duffull, and a Postdoc at the University of Uppsala, Sweden, working with Dr. Jakob Ribbing and Prof. Mats Karlsson. She previously worked as a pharmacometrics consultant at Model Answers Pty Ltd in Brisbane, Australia, before joining Boehringer Ingelheim in 2016.

Key:

Complete
Failed
Available
Locked
MIDD Webinar Series | MIDD in Interstitial Lung Diseases – OFEV® and Beyond
Select the "View On-Demand Recording" button to begin.  |  60 minutes
Select the "View On-Demand Recording" button to begin.  |  60 minutes